# Recent progress in chronic pain-related negative emotions and cognitive dysfunction: insights into the mechanisms underlying neural circuitry

**Authors:** Feng-Xian Hu, Hong-Yun Wu, Yu Wang, Yun-ling Zhang, Wen-Qiang Cui

PMC · DOI: 10.3389/fncel.2026.1759181 · Frontiers in Cellular Neuroscience · 2026-02-05

## TL;DR

This paper reviews recent findings on how chronic pain is linked to negative emotions and cognitive issues through specific brain circuits.

## Contribution

The paper provides a novel synthesis of neural circuit mechanisms underlying chronic pain and its comorbid emotional and cognitive dysfunctions.

## Key findings

- Chronic pain activates or inhibits specific brain circuits linked to anxiety, depression, and cognitive dysfunction.
- Brain regions like the amygdala, thalamus, and lateral habenula are central to these pain-related emotional and cognitive changes.

## Abstract

Pain is a complex sensory and affective experience that is frequently accompanied by comorbid conditions such as anxiety, depression, fear, and cognitive dysfunction, collectively exacerbating patient suffering and disease burden. Despite significant advancements in pain research, the mechanisms underlying chronic pain and its related negative emotions remain inadequately understood. The cerebral cortex, lateral habenula (LHb), thalamus, amygdala, parabrachial nucleus (PBN), hippocampus, and locus coeruleus (LC) are widely associated with chronic pain, chronic pain-related negative emotions, and cognitive dysfunction. In this review, we summarize recent research on the functions of various brain nuclei and their subregions in chronic pain and related negative emotions and cognitive dysfunction from the perspective of neural circuits. By delineating these circuit-level mechanisms, we aim to provide insights that may inform the development of more effective strategies for the clinical diagnosis and treatment of chronic pain and comorbid emotional and cognitive dysfunctions.

Chronic pain (pathological neuropathic pain models and chronic inflammatory pain models) induces the generation and development of anxiety, depression, fear, aversion, and cognitive impairments by activating/inhibiting specific neural circuits in the brain.Illustration of brain pathways associated with pain, showing connections to regions involved in anxiety, aversion, cognitive dysfunction, depression, and fear. Arrows indicate signal pathways between peripheral pain receptors, spinal cord, and various brain areas. Key brain regions such as the cortex, thalamus, amygdala, and different cortical and subcortical structures are labeled. Color-coded lines represent different emotional and cognitive responses linked to pain. A small diagram shows peripheral receptors connected to the spinal cord.

Chronic pain (pathological neuropathic pain models and chronic inflammatory pain models) induces the generation and development of anxiety, depression, fear, aversion, and cognitive impairments by activating/inhibiting specific neural circuits in the brain.

## Full-text entities

- **Genes:** Tacr1 (tachykinin receptor 1) [NCBI Gene 21336] {aka Nk1r, Spr, Tac1r}, Htr2c (5-hydroxytryptamine (serotonin) receptor 2C) [NCBI Gene 15560] {aka 5-HT-1C, 5-HT-2C, 5-HT1C, 5-HT2C, 5-HT2cR, 5-HTR2C}, Chat (choline O-acetyltransferase) [NCBI Gene 290567], Slc17a6 (solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6) [NCBI Gene 140919] {aka 2900073D12Rik, DNPI, VGLUT2}, Oprd1 (opioid receptor, delta 1) [NCBI Gene 18386] {aka DOR, DOR-1, Nbor, mDOR}, Gria1 (glutamate receptor, ionotropic, AMPA1 (alpha 1)) [NCBI Gene 14799] {aka 2900051M01Rik, Glr-1, Glr1, GluA1, GluR-A, GluRA}, Cacng2 (calcium channel, voltage-dependent, gamma subunit 2) [NCBI Gene 12300] {aka B230105C07Rik, B930041E13Rik, stargazer, stargazin, stg, wag}, Camk2a (calcium/calmodulin-dependent protein kinase II alpha) [NCBI Gene 12322] {aka CaMKII, mKIAA0968}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Nsf (N-ethylmaleimide sensitive fusion protein) [NCBI Gene 18195] {aka SKD2}, Htr2a (5-hydroxytryptamine (serotonin) receptor 2A) [NCBI Gene 15558] {aka 5-HT-2, 5-HT-2A, E030013E04, Htr-2, Htr2}, Bdnf (brain derived neurotrophic factor) [NCBI Gene 12064], Scgn (secretagogin, EF-hand calcium binding protein) [NCBI Gene 214189], Ctbp1 (C-terminal binding protein 1) [NCBI Gene 29382] {aka 50-kDaBFA-inducedADP-ribosylatedsubstrate, BARS-50, Bars, CtBP3/BARS}, GRHL3 (grainyhead like transcription factor 3) [NCBI Gene 57822] {aka SOM, TFCP2L4, VWS2}, Prkcd (protein kinase C, delta) [NCBI Gene 18753] {aka D14Ertd420e, PKC[d], PKCdelta, Pkcd}, App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Grp (gastrin releasing peptide) [NCBI Gene 225642] {aka BLP}, CRH (corticotropin releasing hormone) [NCBI Gene 1392] {aka CRF, CRH1}, Crhr1 (corticotropin releasing hormone receptor 1) [NCBI Gene 58959] {aka CRF-R, CRF-R-1, CRF-R1, CRF1, CRFR-1, CRFR1}, Adcyap1 (adenylate cyclase activating polypeptide 1) [NCBI Gene 11516] {aka PACAP}, Oxt (oxytocin) [NCBI Gene 18429] {aka OT, Oxy}, Fos (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14281] {aka D12Rfj1, c-fos, cFos}, Lhb (luteinizing hormone subunit beta) [NCBI Gene 25329], Drd2 (dopamine receptor D2) [NCBI Gene 13489] {aka D2R, Drd-2}, Cel (carboxyl ester lipase) [NCBI Gene 12613] {aka 1810036E18Rik, BAL, BSSL}, Sst (somatostatin) [NCBI Gene 20604] {aka SOM, SRIF, SS, Smst}, Crhr1 (corticotropin releasing hormone receptor 1) [NCBI Gene 12921] {aka CRF-R1alpha, CRF1R, CRFR1, Crhr}, Adra2b (adrenergic receptor, alpha 2b) [NCBI Gene 11552] {aka Adra-2b, [a]2B, a2b-AR, alpha2-C2, alpha2B}, Crh (corticotropin releasing hormone) [NCBI Gene 12918] {aka CRF, Gm1347}, Nos1 (nitric oxide synthase 1, neuronal) [NCBI Gene 18125] {aka 2310005C01Rik, N-NOS, NC-NOS, NO, NOS, NOS-I}, Grm1 (glutamate receptor, metabotropic 1) [NCBI Gene 14816] {aka 4930455H15Rik, Gm10828, Gprc1a, mGluR1, nmf373, rcw}, Oprk1 (opioid receptor, kappa 1) [NCBI Gene 18387] {aka K-OR-1, KOR, KOR-1, MSL-1, Oprk2, R21}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Fosb (Fos B proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 14282], Gria2 (glutamate ionotropic receptor AMPA type subunit 2) [NCBI Gene 29627] {aka GluA2, GluR-K2, GluR2, gluR-B}, Oprd1 (opioid receptor, delta 1) [NCBI Gene 24613], Cck (cholecystokinin) [NCBI Gene 12424], Msn (moesin) [NCBI Gene 17698], crf (cream fur) [NCBI Gene 12917], Tacr3 (tachykinin receptor 3) [NCBI Gene 21338] {aka Nk3r, Nkr, Tac3r}, Tnpo1 (transportin 1) [NCBI Gene 238799] {aka D13Ertd688e, IPO2, Kpnb2, MIP, MIP1, TRN}, Grpr (gastrin releasing peptide receptor) [NCBI Gene 14829] {aka GRP-R}, Htr1a (5-hydroxytryptamine (serotonin) receptor 1A) [NCBI Gene 15550] {aka Gpcr18}, Tnfrsf1b (tumor necrosis factor receptor superfamily, member 1b) [NCBI Gene 21938] {aka CD120b, TNF-R-II, TNF-R2, TNF-R75, TNF-alphaR2, TNFBR}, Strn (striatin, calmodulin binding protein) [NCBI Gene 268980] {aka D130055P19}
- **Diseases:** diabetic (MESH:D003920), fear (MESH:C000719212), Somatosensory cortex (MESH:D020886), irritable (MESH:D001523), vHPC (MESH:D006555), neuroinflammation (MESH:D000090862), anxiety (MESH:D001007), CFA (MESH:D001169), PFC dysfunction (MESH:C536329), EPSC (MESH:D020294), injury (MESH:D014947), inflammation (MESH:D007249), Pain (MESH:D010146), peripheral nerve injury (MESH:D059348), anhedonia (MESH:D059445), craniofacial pain (MESH:D005157), cDLS (MESH:D003635), hyperactivity of (MESH:D006948), post-traumatic stress disorder (MESH:D013313), CCI (MESH:D020208), LPBN (MESH:C537927), acute pain (MESH:D059787), emotional disorders (MESH:D009358), affective disorder (MESH:D019964), memory and learning impairments (MESH:D007859), TN (MESH:C562719), emotional abnormalities (MESH:D000014), LTD (MESH:D000088562), nerve damage (MESH:D000080902), brain impairment (MESH:D001927), migraine (MESH:D008881), allodynia (MESH:D006930), memory impairments (MESH:D008569), cognitive dysfunction (MESH:D003072), PVT (OMIM:614924), SNL (MESH:D061227), Neuropathic pain (MESH:D009437), depression (MESH:D003866), Chronic inflammatory pain (MESH:D059350), social (OMIM:300082), trigeminal neuralgia (MESH:D014277), hypersensitivity (MESH:D004342), peripheral nerve damage (MESH:D010523)
- **Chemicals:** DA (MESH:C025953), MDL100907 (MESH:C079049), LPO (MESH:D008054), pT (MESH:D010984), glutamate (MESH:D018698), NE (MESH:D009638), GABA (MESH:D005680), N-methyl-D-aspartate (MESH:D016202), NO (MESH:D009569), WAY100635 (MESH:C090413), DRN5-HT (-), AMPA (MESH:D018350), Dopaminergic (MESH:D004298), 5-HT (MESH:D012701), ION (MESH:D007477), endocannabinoid (MESH:D063388), sucrose (MESH:D013395)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Lyssavirus rabies (species) [taxon 11292], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Rodentia (rodent, order) [taxon 9989]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12916359/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12916359/full.md

## References

168 references — full list in the complete paper: https://tomesphere.com/paper/PMC12916359/full.md

---
Source: https://tomesphere.com/paper/PMC12916359